From: Abstracts of the ICARE 2024 78th SIAARTI National Congress
 | Group A | Group B | p-value |
---|---|---|---|
Duration first stage | 165 (120 – 278) | 165 (90—285) | 0,6632 |
(minutes; median [25p-75p]) | |||
Duration second stage | 45 (30—65) | 55 (27—88) | 0,1736 |
(minutes; median [25p-75p]) | |||
Caesarean Sectiona | 12 (24.0%) | 8 (14.0%) | 0,1132 |
Maximum oxytocin rate | 1.14 (± 0.6) | 0.91 (± 0.46) | 0.066 |
(IU/h; mean [± ds]) | |||
Fetal heart rate abnormalitiesa | 2 (4.0%) | 10 (17.9%) | 0.025 |
Episiotomya | 21 (56.8%) | 25 (52.1%) | 0,4639 |
Blood loss > 500mla | 23 (46%) | 25 (43.9%) | 0,2729 |
Peridural catether repositioninga | 3 (6.0%) | 0 (0.0%) | 0.061 |
Rescue epidural top-upsa | 3(6.0%) | 1(1.8%) | 0,1722 |
Apgar score at 1 minuteb | 9 (9—9) | 9 (8—9) | 0.069 |
Apgar score at 5 minutesb | 10 (9—10) | 10 (9—10) | 0,6097 |
Neonatal umbelical pHb | 7.28 (7.23—7.33) | 7.27 (7.25—7.33) | 0,2722 |
Neonatal Intensive Care Rooma | 5(10.0%) | 4 (7.1%) | 0,4153 |